M Slavík

748 citations
32 papers · 592 indexed · h-index 12
Topics
Radiopharmaceutical Chemistry and Applications (5 papers)Cancer therapeutics and mechanisms (3 papers)Thallium and Germanium Studies (3 papers)

In The Last Decade

M Slavík

31 papers receiving 541 citations

Peers

M Slavík
Comparison fields: 5 of 106
  • Molecular Biology 191
  • Oncology 127
  • Public Health, Environmental and Occupational Health 89
  • Organic Chemistry 69
  • Pulmonary and Respiratory Medicine 67
Replace Jurij Stekar with:
Jurij Stekar Germany
Myers Ce United States
Shahriar Shahzeidi United States
T. L. Loo United States
Jane Hamlett United Kingdom
Hongmei Luo China
Ching‐Hu Chung Taiwan
Dennis A. Noe United States
Cynthia S. Lancaster United States
Kathryn N. Ham Australia
M Slavík relative to Jurij Stekar Germany Jurij Stekar's profile →
Citations per field
00.5×11×
Jurij Stekar · 1×
Citations per year

Countries citing papers authored by M Slavík

Since Specialization
Citations

This map shows the geographic impact of M Slavík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Slavík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Slavík more than expected).

Fields of papers citing papers by M Slavík

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Slavík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Slavík. The network helps show where M Slavík may publish in the future.

Co-authorship network of co-authors of M Slavík

This figure shows the co-authorship network connecting the top 25 collaborators of M Slavík. A scholar is included among the top collaborators of M Slavík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Slavík. M Slavík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 26
2
Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
34
3 4
4 1
5 7
6 2
7
Therapy for advanced renal cell cancer with spirogermanium: a Southwest Oncology Group Study.
6
8
Phase II study of spirogermanium in advanced adenocarcinoma of the prostate: a Southwest Oncology Group Study.
1
9
An individualized plastic intraoral device for the collection of human parotid saliva.
4
10
Spirogermanium: a new drug with antimalarial activity against chloroquine-resistant Plasmodium falciparum.
10
11
Phase I clinical trial of spirogermanium.
29
12
Changes in amino acid metabolism caused by 6-azauridine triacetate: relevance to cancer treatment.
6
13 2
14
Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
102
15
Clinical studies with nitrosoureas in various solid tumors.
9
16
Changes in preference for NaCl following administration of 6-azauridine and 6-azauridine triacetate.
3
17 14
18
[6-azauridine-triacetate in the therapy of chronic polyarthritis].
1
19 13
20 12

About M Slavík

M Slavík is a scholar working on Health Informatics, Filtration and Separation and Biochemistry, having authored 32 papers that have together received 592 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (5 papers), Cancer therapeutics and mechanisms (3 papers) and Thallium and Germanium Studies (3 papers). The work is most often cited by research in Health Informatics (10 citations), Biochemistry (53 citations) and Oncology (127 citations). M Slavík has collaborated with scholars based in United States, Czechia and France. Frequent co-authors include Oleg S. Selawry, John S. Penta, Lee J. Helman, Daniel D. Von Hoff, Stephen B. Baylin, Albert Sjoerdsma, Martin D. Abeloff, G D Luk, C. A. Griffin and Joachim Hermann. Their work appears in journals such as Journal of Clinical Oncology, Renewable Energy and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026